Role of the Retention Test Homburg in Evaluating Platelet Hyperactivity and in Monitoring Therapy with Antiplatelet Drugs

ABSTRACT

Decreased retention in the retention test Homburg (RTH) indicates a loss of platelet function; increase is associated with an increased activation of platelets, for example, in patients with vascular diseases. Compared with other materials (e.g., collagen, glass pearls, etc.) the filter surface in the retention tubes is nonthrombogenic. Therefore, the RTH seems to be well suited for measuring an in vivo over-reactivity of platelets. In a pilot study using the RTH we evaluated the postoperative over-reactivity of platelets in 14 patients and observed a significant heterogeneity of the platelet population concerning size and stickiness.

Reliable platelet function tests are also necessary for “drug monitoring,” since they deliver important clinical laboratory parameters for efficient control of a therapy with antiplatelet drugs. Therefore, we evaluated in vitro how, after administration of platelet aggregation-inhibiting medications (such as acetylsalicylic acid, Prostaglandin^®, and ReoPro^®) in various concentrations, the adenosine diphosphate (ADP), collagen, ristocetin, or suprarenin increased retention can be reduced.

The reaction of the platelets in platelet-rich plasma of different patients or donors to the addition of ADP is variable. The platelet function inhibitor effect is dose dependent.

In a clinical pilot study, a significant platelet-inhibiting effect of clopidogrel using the RTH has been shown.

KEYWORDS

Retention test - platelet hyperactivity - drug monitoring - clopidogrel

REFERENCES

• 1 Krischek B. Standardisierung und Validierung eines neuen Thrombozytenfunktionstestes zur Messung der Thrombozytenretention unter besonderer Berücksichtigung morphologischer Kriterien. Doctoral Thesis, University of Saarland, Medical Faculty in Homburg/Saar Germany; 2000
• 2 Vollmar B, Slotta J E, Nickels R M, Wenzel E, Menger M D. Comparative analysis of platelet isolation techniques for the in vivo study of the microcirculation.  Microcirculation. 2003;  10 143-152
• 3 Nickels R M, Seyfert U T, Wenzel E, Menger M D, Vollmar B. A simple and reproducible method to reliably assess platelet activation.  Thromb Res. 2003;  110 53-56
• 4 Wieding J U, Matern J, Köstering H, Wermes C, Wenzel E. Retention test Homburg to monitor the adhesive properties of von Willebrand factor after substitution or desmopressin therapy.  Semin Thromb Hemost. 2005;  31 441-448
• 5 Wieding J U, Matern J, Luxembourg B, Bergmann F, Wenzel E, Köstering H. Twofold administration of 0.2 μg/kg BW can improve the efficacy of 0.4 μg/kg desmopressin on primary hemostasis.  Ann Hematol. 2002;  81 A1-A106 , (abst 368)
• 6 Krischek B, Morgenstern E, Mestres P et al.. Adhesion, spreading and aggregation of platelets in flowing blood and the reliability of the retention test Homburg.  Semin Thromb Hemost. 2005;  31 449-457
• 7 Graff J, Klinkhardt U, Gossmann J, Wahl O, Harder S. Effects of P2Y12 inhibition on platelet function in renal transplant patients [abstract].  Clin Pharmacol Ther. 2004;  75 PI14
• 8 Dunnett C W. Pairwise multiple comparisons in the unequal variance case.  J Am Stat Assoc. 1980;  75 796-800
• 9 Rand M L, Leung R, Packham M A. Platelet function assays.  Transfus Apheresis Sci. 2003;  28 307-317
• 10 Schenk J F, König J, Seyfert U T, Krischek B, Heinrich W, Wenzel E. On the influence of platelet size on platelet retention.  J Thromb Haemost. 2001;  , Suppl: CD 3472 (abst)
• 11 Schenk J F, Morgenstern E, Künig J, Seyfert U T, Heinrich W, Wenzel E. Reliability of platelet retention measurement using the Platelet Retention Test Homburg (“RT-H”) [abstract].  J Thromb Haemost. 2001;  (suppl) 384
• 12 Orford J L, Kinlay S, Adams M R, Simon D I, Selwyn A P. Clopidogrel inhibits shear-induced platelet function.  Platelets. 2002;  13 187-189
• 13 Mueller T, Haltmayer M, Poelz W, Haidinger D. Monitoring aspirin 100 mg and clopidogrel 75 mg therapy with the PFA-100 device in patients with peripheral arterial disease.  Vasc Endovascular Surg. 2003;  37 117-123
• 14 Kaufman J S, O'Connor T Z, Zhang J H et al.. Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis.  J Am Soc Nephrol. 2003;  14 2313-2321
• 15 Koscielny J, Aslan T, Meyer O et al.. Use of the platelet reactivity index by Grotemeyer, platelet function analyzer, and retention test Homburg to monitor therapy with antiplatelet drugs.  Semin Thromb Hemost. 2005;  31 464-469